Drug Shortage Report for SUBLOCADE
| Report ID | 155534 |
| Drug Identification Number | 02483092 |
| Brand name | SUBLOCADE |
| Common or Proper name | SUBLOCADE® (buprenorphine extended-release injection) 300 mg / 1.5 mL |
| Company Name | INDIVIOR UK LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | BUPRENORPHINE |
| Strength(s) | 300MG |
| Dosage form(s) | SOLUTION (EXTENDED RELEASE) |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 1 syringe/pack |
| ATC code | N07BC |
| ATC description | |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2022-03-01 |
| Actual start date | 2022-03-01 |
| Estimated end date | 2022-03-05 |
| Actual end date | 2022-03-02 |
| Shortage status | Resolved |
| Updated date | 2022-03-03 |
| Company comments | There is an anticipated short-term backorder of SUBLOCADE® 300 mg supply, that may impact some pharmacies in Canada, for a few days during the first week of March. The anticipated shortage is caused by transportation challenges in North America and will impact the 300 mg dosage strength only. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | THE CHAPLEO BUILDING, HENRY BOOT WAY HULL, -- UNITED KINGDOM HU4 7DY |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2022-03-03 | English | Compare |
| v7 | 2022-03-02 | French | Compare |
| v6 | 2022-03-02 | English | Compare |
| v5 | 2022-03-02 | English | Compare |
| v4 | 2022-03-01 | French | Compare |
| v3 | 2022-03-01 | English | Compare |
| v2 | 2022-02-24 | French | Compare |
| v1 | 2022-02-24 | English | Compare |
Showing 1 to 8 of 8